FdaApplication
NDA 203826
Identifiers
- fda_app_no: NDA203826
Properties
| Property | Value |
|---|---|
| applicant_name | HIKMA PHARMS |
| application_type | NDA |
| approval_date | 2012-12-20 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IMMPHENTIV | PHENYLEPHRINE HYDROCHLORIDE | 1MG/10ML (0.1MG/ML) | SOLUTION;INTRAVENOUS |
| IMMPHENTIV | PHENYLEPHRINE HYDROCHLORIDE | 0.5MG/5ML (0.1MG/ML) | SOLUTION;INTRAVENOUS |
| PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION;INTRAVENOUS |
| PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | 50MG/5ML (10MG/ML) | SOLUTION;INTRAVENOUS |
| PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | 10MG/ML (10MG/ML) | SOLUTION;INTRAVENOUS |
5 products